IDH1 and central nervous system cancer: A total of 79 cases were analyzed (11 normal, 29 IDH‐wildtype low‐grade, 21 IDH‐mutant low‐grade, 13 IDH‐wildtype high‐grade, and 5 IDH‐mutant high‐grade) to reflect the current molecular classification of gliomas (Figure 5A).